G01N33/56983

NOVEL SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS
20210121557 · 2021-04-29 · ·

The present invention relates to a novel genotype of severe fever with thrombocytopenia syndrome viruses and use thereof as an immunogenic composition. The severe fever with thrombocytopenia syndrome viruses of the present invention are genetically different from conventional severe fever with thrombocytopenia syndrome viruses and are novel viruses taxonomically belonging to three sub-groups of genotype B. In view of the vaccine property that specific genotype viruses alone show only limited protective potential, the novel viruses of the present invention may be advantageously used as a vaccine having excellent cross-immunogenicity for SFTSV.

Marker for detecting highly pathogenic influenza virus and use thereof

Provided are a marker for detecting a highly pathogenic influenza virus including a protein mutant prepared by substituting the amino acids 68 and 69 of a PB1-F2 protein, a composition for detecting a highly pathogenic virus including an agent for measuring the protein mutant, and a detection kit including the same, a method for detecting a highly pathogenic virus including measuring the protein mutant, an antiviral composition against influenza A virus including an inhibitor of binding between a PB1-F2 protein in which the amino acids 68 and 69 are substituted and DDX3, and a method for screening an antiviral substance against influenza A virus.

EARLY INFECTIOUS DISEASE SIGN DETECTION DEVICE, EARLY INFECTIOUS DISEASE SIGN DETECTION METHOD, AND RECORDING MEDIUM

An early infectious disease sign detection device includes: an early infectious disease sign detection unit that generates early sign information indicating an early sign that a determination target patient is going to develop an infectious disease, by using learning data indicating a result of learning about biological information of a patient who has developed the infectious disease among a plurality of patients, and biological information acquired for the determination target patient; and an action information output unit that outputs action information for the infectious disease for the determination target patient, based on the early sign information.

BIOAEROSOL DETECTION SYSTEMS AND METHODS OF USE

Described herein are bioaerosol detection systems and methods of use. In embodiments of bioaerosol detection systems and methods of use as described herein, systems and methods detect one or more coronaviruses and/or one or more influenza strains. In embodiments, coronaviruses according to systems and methods as described herein are SARS-CoV-2 coronavirus. In embodiments, influenza strains and/or particles according to the present disclosure are H1N1 influenza.

ELECTRODE FOR ELECTROCHEMICAL MEASUREMENT
20210102912 · 2021-04-08 ·

Provided is an electrode for electrochemical measurement for detecting or quantitatively determining a target substance, the electrode comprising: a complex supported on a surface of the electrode, wherein the complex is a complex comprising a probe for the target substance, a quantum dot which binds to the probe and is doped with nitrogen and sulfur, and a conductive polymer nanowire in which a metal nanoparticle is embedded.

DIAGNOSTIC ASSAYS AND RELATED METHODS

Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.

Bioaerosol detection systems and methods of use

Described herein are bioaerosol detection systems and methods of use. In embodiments of bioaerosol detection systems and methods of use as described herein, systems and methods detect one or more coronaviruses and/or one or more influenza strains. In embodiments, coronaviruses according to systems and methods as described herein are SARS-CoV-2 coronavirus. In embodiments, influenza strains and/or particles according to the present disclosure are H1N1 influenza.

WHOLE VIRUS QUANTUM MECHANICAL TUNNELING CURRENT AND ELECTRONIC SENSORS
20210123883 · 2021-04-29 ·

A field effect transistor (FET) biosensor for virus detection of a selected virus within a sample volume is disclosed. The FET comprises a semiconductor substrate, a source and drain electrode on the substrate, the electrodes spaced to form a channel. A gate electrode carried on the substrate and located in the channel between the source and drain electrodes. An insulating layer is coupled to a top surface of the gate electrode and a bottom surface of the source and drain electrodes, with an open channel above the insulating layer. A channel material is coupled to the insulating layer. Aptamers are oriented within the open channel to bind to the channel material and with the selected virus to enable a detection of the selected virus by the FET biosensor based on a change in drain-source current at a selected gate voltage.

SYSTEMS AND METHODS FOR SENSING USING CONSUMER ELECTRONIC DEVICES

Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.

WHITE LIGHT EMISSIVE SPECIES AND RELATED METHODS

Embodiments described herein generally relate to: sensing and/or authentication using luminescence imaging; diagnostic assays, systems, and related methods; temporal thermal sensing and related methods; and/or to emissive species, such as those excitable by white light, and related systems and methods.